# Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

> **NCT00880893** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1198 (actual)

## Conditions studied

- Dengue Fever
- Dengue Hemorrhagic Fever
- Dengue Virus
- Dengue Diseases

## Interventions

- **BIOLOGICAL:** CYD Dengue vaccine
- **BIOLOGICAL:** NaCl + influenza virus or hepatitis A vaccine

## Key facts

- **NCT ID:** NCT00880893
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10-14
- **Target enrollment:** 1198 (ACTUAL)
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880893, "Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00880893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*